PHARNEXT: Shareholder Letter: Time to reveal Pharnext true value
PARIS, France, January 11th, 2023, 8:30 am CET - Pharnext SA (FR001400BV89 - ALPHA) (the "Company"), an advanced late-clinical stage biopharmaceutical company developing novel therapeutics for rare
Source: finanznachrichten.de